ZNTL
Zentalis Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $186.35M
- Employees
- 106
- Latest publication
- 2026-09-29
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 28,716,000USD | 29,488,000USD | 22,950,000USD | 27,610,000USD | 27,247,000USD | 32,973,000USD | 36,824,000USD | 48,386,000USD |
| Total Operating Expenses | 37,855,000USD | 37,393,000USD | 33,734,000USD | 36,058,000USD | 45,623,000USD | 76,714,000USD | 51,432,000USD | 65,147,999USD |
| Income Tax Expense | 120,000USD | 442,000USD | 0USD | 0USD | — | -205,000USD | -27,000USD | 266,000USD |
| Net Income | -35,232,000USD | -35,216,000USD | -26,691,000USD | -26,874,000USD | -48,279,000USD | -47,472,000USD | -40,158,000USD | -88,277,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 26,865,000USD | 0USD | 0USD |
| Cost Of Revenue | — | 157,000USD | — | — | 262,000USD | 317,000USD | 321,000USD | 327,000USD |
| Gross Profit | — | -157,000USD | — | — | -262,000USD | 26,865,000USD | -321,000USD | -327,000USD |
| Selling General Administrative | — | 7,905,000USD | 10,784,000USD | 8,448,000USD | 10,580,000USD | 40,005,000USD | 14,608,000USD | 16,762,000USD |
| Operating Income | — | -37,393,000USD | -33,734,000USD | -36,058,000USD | -45,623,000USD | -49,849,000USD | -51,432,000USD | -65,147,999USD |
| Income Before Tax | — | -34,774,000USD | -26,691,000USD | -26,874,000USD | -48,279,000USD | -47,677,000USD | -40,185,000USD | -88,011,000USD |
| Tax Provision | — | 442,000USD | — | — | 0USD | -205,000USD | -27,000USD | 266,000USD |
| Net Income From Continuing Ops | — | -35,216,000USD | — | — | -48,279,000USD | -47,472,000USD | -40,158,000USD | -88,277,000USD |
| Ebit | — | -34,774,000USD | — | — | -37,827,000USD | -46,113,000USD | -40,185,000USD | -88,011,000USD |
| Ebitda | — | -34,617,000USD | — | — | -37,565,000USD | -45,796,000USD | -39,864,000USD | -87,684,001USD |
| Depreciation And Amortization | — | 157,000USD | — | — | 262,000USD | 317,000USD | 321,000USD | 326,999USD |
| Reconciled Depreciation | — | 157,000USD | — | — | 262,000USD | 317,000USD | 321,000USD | 327,000USD |
| Total Other Income Expense Net | — | 2,619,000USD | 7,043,000USD | 9,184,000USD | -2,656,000USD | 2,172,000USD | 11,247,000USD | -22,863,001USD |
| Minority Interest | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| General And Administrative Expenses | — | — | 10,784,000USD | 8,448,000USD | — | — | — | — |
| Unclassified Operating Expenses | — | — | — | — | 7,796,000USD | 3,736,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 327,001USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 67,425,000USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 107,295,000USD | 167,768,000USD | 235,158,000USD | 172,734,000USD | 84,901,000USD | 38,386,000USD |
| Selling General Administrative | 37,717,000USD | 87,115,000USD | 59,398,000USD | 54,553,000USD | 33,886,000USD | 8,459,000USD |
| General And Administrative Expenses | 37,717,000USD | — | — | — | — | — |
| Total Operating Expenses | 152,808,000USD | 258,619,000USD | 299,509,000USD | 227,287,000USD | 118,787,000USD | 46,845,000USD |
| Operating Income | -152,808,000USD | -191,194,000USD | -299,509,000USD | -227,287,000USD | -118,787,000USD | -46,845,000USD |
| Total Other Income Expense Net | 16,190,000USD | 25,504,000USD | 6,603,000USD | -10,295,000USD | 683,000USD | 482,000USD |
| Income Before Tax | -136,618,000USD | -165,690,000USD | -292,906,000USD | -237,582,000USD | -118,104,000USD | -46,363,000USD |
| Income Tax Expense | 442,000USD | 177,000USD | -601,000USD | -469,000USD | 444,000USD | 15,000USD |
| Equity Method Income Loss | 0USD | — | — | — | — | — |
| Net Income | -137,060,000USD | -165,839,000USD | -292,191,000USD | -236,806,000USD | -117,841,000USD | -45,663,000USD |
| Minority Interest | 0USD | 28,000USD | 105,000USD | -307,000USD | 24,795,000USD | 6,821,000USD |
| Cost Of Revenue | — | 1,289,000USD | 1,389,000USD | 1,426,000USD | 160,000USD | 111,000USD |
| Gross Profit | — | 67,425,000USD | -1,389,000USD | -1,426,000USD | -160,000USD | -111,000USD |
| Unclassified Operating Expenses | — | 3,736,000USD | 3,564,000USD | — | — | — |
| Tax Provision | — | 177,000USD | -826,000USD | -469,000USD | 444,000USD | 15,000USD |
| Net Income From Continuing Ops | — | -165,867,000USD | -286,350,000USD | -220,831,000USD | -118,548,000USD | -46,378,000USD |
| Ebit | — | -187,458,000USD | -248,988,000USD | -235,007,000USD | -118,787,000USD | -46,845,000USD |
| Ebitda | — | -186,169,000USD | -247,599,000USD | -233,581,000USD | -118,627,000USD | -46,734,000USD |
| Depreciation And Amortization | — | 1,289,000USD | 1,389,000USD | 1,426,000USD | 160,000USD | 111,000USD |
| Reconciled Depreciation | — | 1,289,000USD | 1,411,000USD | 1,426,000USD | 160,000USD | 111,000USD |
| Selling And Marketing Expenses | — | — | 1,389,000USD | — | — | — |
| Interest Expense | — | — | — | 2,575,000USD | 2,233,000USD | 1,197,000USD |
| Non Operating Income Net Other | — | — | — | -16,282,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -236,806,000USD | -117,841,000USD | -45,663,000USD |
| Interest Income | — | — | — | — | — | 498,000USD |
| Net Interest Income | — | — | — | — | — | 498,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 215,330,000USD | 253,066,000USD | 288,967,000USD | 327,250,000USD | 351,707,000USD | 384,021,000USD | 430,337,000USD | 450,661,000USD |
| Cash And Equivalents | 24,783,000USD | 31,930,000USD | 35,995,000USD | 39,072,000USD | 37,599,000USD | — | — | — |
| Total Current Assets | 181,279,000USD | 218,096,000USD | 253,191,000USD | 288,302,000USD | 311,596,000USD | 342,882,000USD | 386,066,000USD | 400,270,000USD |
| Other Current Assets | 6,671,000USD | 6,338,000USD | 7,298,000USD | 7,605,000USD | 8,165,000USD | 10,429,000USD | 9,982,000USD | 9,018,000USD |
| Total Liabilities | 71,684,000USD | 70,386,000USD | 72,763,000USD | 74,376,000USD | 77,212,000USD | — | — | — |
| Total Current Liabilities | 37,626,000USD | 35,236,000USD | 36,559,000USD | 37,168,000USD | 39,022,000USD | 49,430,000USD | 52,725,000USD | 54,877,000USD |
| Other Current Liabilities | 29,484,000USD | 27,858,000USD | 29,351,000USD | 30,137,000USD | 35,303,000USD | — | — | — |
| Other Non Current Liabilities | 500,000USD | 500,000USD | 500,000USD | 500,000USD | 500,000USD | — | — | — |
| Total Stockholder Equity | 143,646,000USD | 182,680,000USD | 216,204,000USD | 252,874,000USD | 274,495,000USD | 295,382,000USD | 337,186,000USD | 354,331,000USD |
| Total Equity Including Noncontrolling Interest | 143,646,000USD | 182,680,000USD | 216,204,000USD | 252,874,000USD | 274,495,000USD | — | — | — |
| Property Plant Equipment Net | 27,295,000USD | 28,248,000USD | 29,041,000USD | 33,115,000USD | 34,262,000USD | 35,172,000USD | 37,227,000USD | 38,419,000USD |
| Accounts Payable | 8,142,000USD | 7,378,000USD | 7,208,000USD | 7,031,000USD | 3,719,000USD | 7,769,000USD | 7,438,000USD | 8,202,000USD |
| Common Stock | 72,000USD | 71,000USD | 69,000USD | 72,000USD | 72,000USD | 72,000USD | 71,000USD | 71,000USD |
| Retained Earnings | -1,269,093,000USD | -1,226,807,000USD | -1,191,455,000USD | -1,156,239,000USD | -1,129,548,000USD | -1,102,674,000USD | -1,054,395,000USD | -1,006,923,000USD |
| Accumulated Other Comprehensive Income | -78,000USD | -50,000USD | 196,000USD | 186,000USD | 59,000USD | 358,000USD | 557,999USD | 1,594,000USD |
| Short Term Debt | — | 4,001,000USD | 3,873,000USD | 3,749,000USD | 3,627,000USD | 3,509,000USD | 3,072,000USD | 2,809,000USD |
| Cash And Short Term Investments | — | — | 35,995,000USD | 41,478,000USD | 54,390,000USD | 332,453,000USD | 371,084,000USD | 391,252,000USD |
| Short Term Investments | — | — | 0USD | 2,406,000USD | 16,791,000USD | 290,524,000USD | 337,183,000USD | 349,932,000USD |
| Net Receivables | — | — | 0USD | 0USD | 0USD | — | 5,000,000USD | — |
| Total Liab | — | — | — | — | — | 88,639,000USD | 93,151,000USD | 96,330,000USD |
| Other Current Liab | — | — | — | — | — | 38,152,000USD | 42,215,000USD | 43,866,000USD |
| Capital Stock | — | — | — | — | — | 72,000USD | 71,000USD | 71,000USD |
| Cash | — | — | — | — | — | 41,929,000USD | 33,901,000USD | 41,320,000USD |
| Net Debt | — | — | — | — | — | 231,000USD | 8,748,000USD | 1,946,000USD |
| Short Long Term Debt Total | — | — | — | — | — | 42,160,000USD | 42,649,000USD | 43,266,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | 37,513,000USD | 41,501,000USD | 42,376,000USD |
| Common Stock Shares Outstanding | — | — | — | — | — | 71,678,000shares | 71,237,572shares | 71,111,000shares |
| Non Current Assets Total | — | — | — | — | — | 41,139,000USD | 44,271,000USD | 50,391,000USD |
| Non Current Liabilities Total | — | — | — | — | — | 39,209,000USD | 40,426,000USD | 41,453,000USD |
| Non Current Liabilities Other | — | — | — | — | — | 558,000USD | 849,000USD | 996,000USD |
| Non Currrent Assets Other | — | — | — | — | — | 3,340,000USD | 4,417,000USD | 5,609,000USD |
| Net Working Capital | — | — | — | — | — | 293,452,000USD | 333,341,000USD | 345,393,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | 2,627,000USD | 2,627,000USD | 2,627,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 38,651,000USD | 39,577,000USD | 40,457,000USD |
| Unclassified Equity | — | — | — | — | — | 1,397,554,000USD | 1,390,881,001USD | 1,359,518,000USD |
| Good Will | — | — | — | — | — | — | 0USD | 3,736,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 288,967,000USD | 430,337,000USD | 562,027,000USD | 553,457,000USD | 472,025,000USD | 365,555,000USD | 88,232,000USD | 40,998,000USD |
| Cash And Equivalents | 35,995,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 35,995,000USD | 371,084,000USD | 482,919,000USD | 437,371,000USD | 340,130,000USD | 338,505,000USD | 67,246,000USD | 25,154,000USD |
| Short Term Investments | 0USD | 337,183,000USD | 454,881,000USD | 394,302,000USD | 280,173,000USD | 283,554,000USD | — | — |
| Total Current Assets | 253,191,000USD | 386,066,000USD | 496,718,000USD | 451,933,000USD | 350,770,000USD | 345,104,000USD | 68,891,000USD | 26,677,000USD |
| Other Current Assets | 7,298,000USD | 9,982,000USD | 13,799,000USD | 14,562,000USD | 8,005,000USD | 6,599,000USD | 1,505,000USD | 606,000USD |
| Total Liabilities | 72,763,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 36,559,000USD | 52,725,000USD | 69,367,000USD | 56,647,000USD | 43,944,000USD | 28,601,000USD | 14,897,000USD | 6,208,000USD |
| Other Current Liabilities | 29,351,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 500,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 216,204,000USD | 337,186,000USD | 437,284,000USD | 433,803,000USD | 363,954,000USD | 308,582,000USD | 61,600,000USD | 24,770,000USD |
| Total Equity Including Noncontrolling Interest | 216,204,000USD | — | — | — | — | — | — | — |
| Net Receivables | 0USD | 5,000,000USD | — | 7,041,000USD | 2,635,000USD | 417,000USD | 140,000USD | 917,000USD |
| Property Plant Equipment Net | 29,041,000USD | 37,227,000USD | 41,735,000USD | 50,078,000USD | 52,839,000USD | 3,619,000USD | 2,836,000USD | 260,000USD |
| Accounts Payable | 7,208,000USD | 7,438,000USD | 14,926,000USD | 11,247,000USD | 11,590,000USD | 8,661,000USD | 4,289,000USD | 3,431,000USD |
| Short Term Debt | 3,873,000USD | 3,072,000USD | 2,623,000USD | 2,162,000USD | 1,453,000USD | 902,000USD | 781,000USD | — |
| Common Stock | 69,000USD | 71,000USD | 70,000USD | 59,000USD | 45,000USD | 41,000USD | 2,887,000USD | 2,270,000USD |
| Retained Earnings | -1,191,455,000USD | -1,054,395,000USD | -888,556,000USD | -596,365,000USD | -359,559,000USD | -200,834,000USD | -82,993,000USD | -37,330,000USD |
| Accumulated Other Comprehensive Income | 196,000USD | 557,999USD | 2,194,000USD | -1,353,000USD | -125,000USD | 36,000USD | -167,000USD | -56,000USD |
| Total Liab | — | 93,151,000USD | 124,636,000USD | 119,433,000USD | 107,543,000USD | 32,178,000USD | 19,811,000USD | 8,692,000USD |
| Other Current Liab | — | 42,215,000USD | 51,256,000USD | 43,238,000USD | 29,930,000USD | 19,038,000USD | 9,827,000USD | 2,777,000USD |
| Capital Stock | — | 71,000USD | 70,000USD | 59,000USD | 45,000USD | 41,000USD | 25,000USD | 62,100,000USD |
| Good Will | — | 0USD | 3,736,000USD | 3,736,000USD | 3,736,000USD | 3,736,000USD | 3,736,000USD | 3,736,000USD |
| Cash | — | 33,901,000USD | 28,038,000USD | 43,069,000USD | 59,957,000USD | 54,951,000USD | 67,246,000USD | 25,154,000USD |
| Net Debt | — | 8,748,000USD | 17,735,000USD | 4,259,000USD | -14,045,000USD | -52,952,000USD | -64,770,000USD | -25,154,000USD |
| Short Long Term Debt Total | — | 42,649,000USD | 45,773,000USD | 47,328,000USD | 45,912,000USD | 1,999,000USD | 2,476,000USD | — |
| Property Plant Equipment Gross | — | 41,501,000USD | 44,883,000USD | 7,705,000USD | 53,631,000USD | 3,619,000USD | 2,836,000USD | 260,000USD |
| Common Stock Shares Outstanding | — | 71,080,000shares | 65,409,000shares | 52,857,000shares | 42,688,000shares | 41,040,286shares | 35,878,524shares | 18,058,000shares |
| Non Current Assets Total | — | 44,271,000USD | 65,309,000USD | 101,524,000USD | 121,255,000USD | 20,451,000USD | 19,340,999USD | 14,321,000USD |
| Non Current Liabilities Total | — | 40,426,000USD | 55,269,000USD | 62,786,000USD | 63,599,000USD | 3,577,000USD | 4,914,000USD | 2,484,000USD |
| Non Current Liabilities Other | — | 849,000USD | 1,780,000USD | 2,620,000USD | — | — | 1,700,000USD | 21,000USD |
| Non Currrent Assets Other | — | 4,417,000USD | 6,818,000USD | 9,723,000USD | 7,040,000USD | 4,296,000USD | 2,974,999USD | 1,525,000USD |
| Net Working Capital | — | 333,341,000USD | 427,351,000USD | 395,286,000USD | 306,826,000USD | 316,503,000USD | 69,170,000USD | 20,469,000USD |
| Unclassified Non Current Assets | — | 2,627,000USD | 13,020,000USD | 4,424,000USD | 10,478,000USD | -4,296,000USD | — | -1,525,000USD |
| Unclassified Non Current Liabilities | — | 39,577,000USD | 53,489,000USD | 56,693,000USD | 61,977,000USD | 1,097,000USD | -1,790,000USD | — |
| Unclassified Equity | — | 1,390,881,001USD | 1,323,506,000USD | 1,031,403,000USD | 723,548,000USD | 509,298,000USD | 141,848,000USD | -2,214,000USD |
| Current Deferred Revenue | — | — | 281,000USD | -2,162,000USD | — | — | — | 223,423USD |
| Long Term Investments | — | — | 0USD | 21,213,000USD | 37,495,000USD | 0USD | — | — |
| Other Liab | — | — | — | 3,473,000USD | 1,622,000USD | 2,480,000USD | 4,163,000USD | 2,484,000USD |
| Other Assets | — | — | — | 12,350,000USD | 9,667,000USD | 4,296,000USD | 0USD | 1,525,000USD |
| Inventory | — | — | — | -7,041,000USD | -4,439,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 433,803,000USD | 360,218,000USD | 296,046,000USD | -92,642,000USD | -47,596,000USD |
| Unclassified Current Assets | — | — | — | -7,041,000USD | — | — | — | — |
| Intangible Assets | — | — | — | — | — | 8,800,000USD | 8,800,000USD | 8,800,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | 841,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 151,000USD | 157,000USD | 160,000USD | 160,000USD | 262,000USD | 317,000USD | 321,000USD | 327,000USD |
| Stock Based Compensation | 3,197,000USD | 3,122,000USD | 4,828,000USD | 6,286,000USD | 6,486,000USD | 31,363,000USD | 10,362,000USD | 12,711,000USD |
| Change To Liabilities | -1,451,000USD | — | — | — | — | — | — | — |
| Change In Working Capital | -478,000USD | -1,378,000USD | -1,170,000USD | -8,328,000USD | 1,754,000USD | -4,514,000USD | -7,258,000USD | 14,099,000USD |
| Operating Cash Flow | -32,956,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -34,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -181,000USD |
| Net Investments | 30,048,000USD | — | — | — | — | — | — | — |
| Investing Cash Flow | 30,014,000USD | — | — | — | — | — | — | — |
| Common Stock Issuance | 331,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -1,454,000USD | -9,976,000USD | — | — | — | — | -48,392,000USD | -34,490,000USD |
| Financing Cash Flow | -1,123,000USD | — | — | — | — | — | — | — |
| Change In Cash | -4,065,000USD | -3,077,000USD | 1,473,000USD | -4,330,000USD | 8,028,000USD | -7,419,000USD | 4,344,000USD | -640,000USD |
| End Cash Flow | 34,557,000USD | — | — | — | — | — | — | — |
| Net Income | — | -35,216,000USD | -26,691,000USD | -26,874,000USD | -48,279,000USD | -47,472,000USD | -40,158,000USD | -88,277,000USD |
| Other Non Cash Items | — | 2,375,000USD | -4,090,000USD | -5,952,000USD | 7,141,000USD | -19,396,000USD | -7,312,000USD | 26,001,000USD |
| Total Cash From Operating Activities | — | -30,940,000USD | -26,963,000USD | -34,708,000USD | -32,636,000USD | -39,702,000USD | -44,045,000USD | -35,139,000USD |
| Free Cash Flow | — | -30,940,000USD | -26,963,000USD | -34,708,000USD | -32,636,000USD | -39,702,000USD | -44,045,000USD | -35,320,000USD |
| Investments | — | 32,320,000USD | 28,321,000USD | 30,378,000USD | 40,475,000USD | 32,283,000USD | 48,243,000USD | 34,490,000USD |
| Total Cashflows From Investing Activities | — | 32,449,000USD | 28,321,000USD | 30,378,000USD | 40,475,000USD | 32,283,000USD | 48,243,000USD | 34,490,000USD |
| Total Cash From Financing Activities | — | -4,586,000USD | 115,000USD | 0USD | 189,000USD | 0USD | 92,000USD | 9,000USD |
| Issuance Of Capital Stock | — | 5,390,000USD | 115,000USD | 0USD | 189,000USD | 0USD | 92,000USD | 9,000USD |
| Begin Period Cash Flow | — | 41,699,000USD | 40,226,000USD | 44,556,000USD | 36,528,000USD | 43,947,000USD | 36,976,000USD | 37,616,000USD |
| End Period Cash Flow | — | 38,622,000USD | 41,699,000USD | 40,226,000USD | 44,556,000USD | 36,528,000USD | 41,320,000USD | 36,976,000USD |
| Other Cashflows From Investing Activities | — | -440,000USD | — | — | 5,000USD | — | 65,000USD | 65,000USD |
| Change To Account Receivables | — | — | — | 0USD | 5,000,000USD | -5,000,000USD | — | 0USD |
| Other Cashflows From Financing Activities | — | — | — | — | — | 349,000USD | 48,243,000USD | 34,490,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 241,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 739,000USD | 1,289,000USD | 1,389,000USD | 1,426,000USD | 544,000USD | 160,000USD | 111,000USD | 51,000USD |
| Stock Based Compensation | 20,722,000USD | 67,269,000USD | 54,822,000USD | 46,840,000USD | 35,737,000USD | 23,146,000USD | 617,000USD | 308,000USD |
| Deferred Income Tax | 51,000USD | — | — | — | — | — | — | — |
| Change To Account Receivables | 5,000,000USD | -5,000,000USD | 0USD | 108,000USD | 413,000USD | -277,000USD | 777,000USD | -254,000USD |
| Change To Liabilities | -17,316,000USD | — | — | 15,527,000USD | 13,916,000USD | 14,307,000USD | 7,123,000USD | 977,000USD |
| Change In Working Capital | -9,323,000USD | -16,540,000USD | 5,864,000USD | 13,252,000USD | 16,605,000USD | 7,844,000USD | 6,507,000USD | -1,178,000USD |
| Operating Cash Flow | -125,247,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | 0USD | -221,000USD | -583,000USD | -2,548,000USD | -6,107,000USD | -758,000USD | -352,000USD | -227,000USD |
| Net Investments | 110,512,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | 21,111,000USD | — | -29,583,000USD | — | -14,307,992USD | 19,182,000USD | — | — |
| Investing Cash Flow | 131,623,000USD | — | — | — | — | — | — | — |
| Common Stock Issuance | 304,000USD | — | — | — | — | — | — | — |
| Net Common Stock Issuance | -9,976,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 5,390,000USD | — | 281,761,000USD | 114,180,000USD | 179,668,146USD | -18,424,000USD | -81,876,000USD | -9,456,000USD |
| Financing Cash Flow | -4,282,000USD | — | — | — | — | — | — | — |
| Change In Cash | 2,094,000USD | 5,809,000USD | -14,977,000USD | -16,888,000USD | 6,313,000USD | -11,218,000USD | 42,335,000USD | -15,006,000USD |
| End Cash Flow | 38,622,000USD | — | — | — | — | — | — | — |
| Net Income | — | -165,867,000USD | -292,191,000USD | -237,113,000USD | -166,093,000USD | -118,548,000USD | -46,378,000USD | -23,432,000USD |
| Other Non Cash Items | — | -57,011,000USD | 23,147,000USD | 12,613,000USD | -38,376,000USD | 556,000USD | -7,776,000USD | -2,365,000USD |
| Total Cash From Operating Activities | — | -170,860,000USD | -207,822,000USD | -163,751,000USD | -154,093,000USD | -86,825,000USD | -39,143,000USD | -24,251,000USD |
| Free Cash Flow | — | -171,081,000USD | -208,405,000USD | -166,299,000USD | -160,200,000USD | -87,583,000USD | -39,495,000USD | -24,478,000USD |
| Investments | — | 176,561,000USD | -14,292,000USD | -111,632,000USD | 2,312,000USD | -284,832,000USD | -352,000USD | -227,000USD |
| Total Cashflows From Investing Activities | — | 176,561,000USD | -44,458,000USD | -114,180,000USD | -18,115,000USD | -284,832,000USD | -352,000USD | -227,000USD |
| Total Cash From Financing Activities | — | 108,000USD | 237,303,000USD | 261,043,000USD | 178,521,000USD | 360,439,000USD | 81,830,000USD | 9,472,000USD |
| Sale Purchase Of Stock | — | 0USD | 0USD | 261,043,000USD | -1,146USD | 346,211,000USD | 81,876,000USD | 9,472,000USD |
| Issuance Of Capital Stock | — | 349,000USD | 287,044,000USD | 261,043,000USD | 179,667,000USD | 342,015,000USD | 81,876,000USD | 9,472,000USD |
| Begin Period Cash Flow | — | 30,719,000USD | 45,696,000USD | 62,584,000USD | 56,271,000USD | 67,489,000USD | 25,154,000USD | 40,160,000USD |
| End Period Cash Flow | — | 36,528,000USD | 30,719,000USD | 45,696,000USD | 62,584,000USD | 56,271,000USD | 67,489,000USD | 25,154,000USD |
| Other Cashflows From Investing Activities | — | 65,000USD | — | -111,632USD | -12,008USD | -18,424,000USD | — | — |
| Other Cashflows From Financing Activities | — | -241,000USD | -44,458,000USD | -114,180,000USD | -1,146,000USD | 32,652,000USD | 81,830,000USD | 9,456,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -16,888,000USD | 6,313,000USD | -11,218,000USD | — | — |
| Change To Inventory | — | — | — | — | 881,000USD | -5,519,000USD | -1,508,000USD | -1,861,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -2,510,000USD | — | 7,776,000USD | 2,365,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD |
|---|---|---|
| Depreciation | 582,000USD | 422,000USD |
| Stock Based Compensation | 17,600,000USD | 12,772,000USD |
| Change To Liabilities | -16,583,000USD | -14,607,000USD |
| Change In Working Capital | -12,892,000USD | -11,595,000USD |
| Operating Cash Flow | -94,307,000USD | -67,344,000USD |
| Capital Expenditures | 0USD | 0USD |
| Net Investments | 98,605,000USD | 70,284,000USD |
| Unclassified Investing Cash Flow | 569,000USD | 569,000USD |
| Investing Cash Flow | 99,174,000USD | 70,853,000USD |
| Common Stock Issuance | 304,000USD | 189,000USD |
| Financing Cash Flow | 304,000USD | 189,000USD |
| Change In Cash | 5,171,000USD | 3,698,000USD |
| End Cash Flow | 41,699,000USD | 40,226,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.